OBJECTIVE: To establish whether sickle cell disease (SCD) affects cognitive functioning in children with no evidence of cerebral infarction. METHODS: We conducted a meta-analysis of studies of cognition in SCD to determine the size of any statistical difference between children with SCD and controls. Methodological factors were evaluated according to the size and frequency of group differences. RESULTS: There were small but reliable decrements in cognitive functioning on IQ measures (4.3-point difference overall). The most methodologically rigorous studies showed a highly similar pattern. Sampling issues associated with the effect size for IQ were identified. Measures of specific abilities appear more sensitive than IQ scores to cognitive decrements in SCD. CONCLUSIONS: SCD is associated with cognitive effects even in the absence of cerebral infarction. The causes of this cognitive decrement may include direct effects of SCD on brain function or indirect effects of chronic illness.
OBJECTIVE: To establish whether sickle cell disease (SCD) affects cognitive functioning in children with no evidence of cerebral infarction. METHODS: We conducted a meta-analysis of studies of cognition in SCD to determine the size of any statistical difference between children with SCD and controls. Methodological factors were evaluated according to the size and frequency of group differences. RESULTS: There were small but reliable decrements in cognitive functioning on IQ measures (4.3-point difference overall). The most methodologically rigorous studies showed a highly similar pattern. Sampling issues associated with the effect size for IQ were identified. Measures of specific abilities appear more sensitive than IQ scores to cognitive decrements in SCD. CONCLUSIONS:SCD is associated with cognitive effects even in the absence of cerebral infarction. The causes of this cognitive decrement may include direct effects of SCD on brain function or indirect effects of chronic illness.
Authors: Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli Journal: Pediatr Blood Cancer Date: 2016-07-09 Impact factor: 3.167
Authors: Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Yasheng Chen; Cihat Eldeniz; Monica L Hulbert; Michael M Binkley; James N Rhodes; Joshua S Shimony; Robert C McKinstry; Katie D Vo; Hongyu An; Jin-Moo Lee; Andria L Ford Journal: Pediatr Neurol Date: 2016-12-07 Impact factor: 3.372
Authors: Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun Journal: Am J Hematol Date: 2014-02 Impact factor: 10.047
Authors: Lori E Crosby; Russell E Ware; Alana Goldstein; Ashley Walton; Naomi E Joffe; Craig Vogel; Maria T Britto Journal: Pediatr Blood Cancer Date: 2016-08-30 Impact factor: 3.167